SCHEMBL29497376

SCHEMBL29497376

Cc1nc(OC2CCC3(CC2)CNC3)ccc1C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29427075 0.84 — —
SCHEMBL25410315 0.84 — —
SCHEMBL30503570 0.82 — —
SCHEMBL29497352 0.81 PDE2A (0.31) —
SCHEMBL25413735 0.77 ACACB (0.31) —
SCHEMBL29497354 0.75 TDO2 (0.35) —
SCHEMBL29497455 0.75 — —
SCHEMBL25410707 0.75 — —
SCHEMBL29426770 0.74 ABHD6 (0.35) —
SCHEMBL26739475 0.74 ABHD6 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-06-27 — — US disclosed
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-31 — — US disclosed
US-20220089538-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-03-24 — — US disclosed
Send feedback